Latest Breaking News On - Sunil mehra - Page 4 : comparemela.com

New Delhi, May 18: Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Private Limited), a global values-based, R&D-driven biopharmaceutical leader conducted dissemination of its public health initiatives in strengthening the health system for rare diseases (RD) in India. These initiatives aim to improve access to healthcare for rare disease patients who otherwise face significant outcomes like childhood disabilities and life-long morbidity, early mortality, and progressively poor Quality of Life. The meeting was witnessed by Takeda s partners including APCO Worldwide, MAMTA Health Institute for Mother and Child, US-India Strategic Partnership Forum, and DakshamA Health and Education.

New delhiUnited statesJoyeta ghoshalSunil mehraRuchi sogarwalTakeda public health initiativeDakshama healthTakeda biopharmaceuticals india privateHead of corporate affairsExchange commissionNational policy for rare diseasesBaxalta bioscience india privateTakeda pharmaceutical company limitedPublic healthUs india strategic partnership forumManagement software for pharmaceutical business